135 related articles for article (PubMed ID: 6971771)
1. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
[TBL] [Abstract][Full Text] [Related]
2. Studies on circulating soluble immune complexes of the liver disease. 7. Immune complexes in the clinical course and their ultracentrifugal analysis.
Narumoto J
Gastroenterol Jpn; 1981; 16(2):186-92. PubMed ID: 6262181
[TBL] [Abstract][Full Text] [Related]
3. Studies on circulating soluble immune complexes of the liver disease. 2. Serum inhibitory activity of polyclonal rheumatoid factor binding to IgG-sepharose.
Narumoto J; Arima T; Kunishi K; Yasuhara T; Suwaki K; Shimomura H; Nagashima H
Gastroenterol Jpn; 1979 Dec; 14(6):617-20. PubMed ID: 527797
[TBL] [Abstract][Full Text] [Related]
4. Studies on circulating soluble immune complexes of the liver disease. 1. Inhibition assay of polyclonal rheumatoid factor binding to IgG-sepharose.
Narumoto J; Arima T; Kunishi K; Yasuhara T; Suwaki K; Shimomura H; Nagashima H
Gastroenterol Jpn; 1979 Dec; 14(6):611-6. PubMed ID: 393565
[TBL] [Abstract][Full Text] [Related]
5. Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.
Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
Gastroenterol Jpn; 1980; 15(1):27-32. PubMed ID: 6153628
[TBL] [Abstract][Full Text] [Related]
6. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
Medof ME
J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
[TBL] [Abstract][Full Text] [Related]
7. Influence of serum complement and rheumatoid factor on detection of immune complexes by the C1q and monoclonal rheumatoid factor solid-phase assay.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Immunol Methods; 1984 Oct; 73(2):301-11. PubMed ID: 6436384
[TBL] [Abstract][Full Text] [Related]
8. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
9. Circulating IgA immune complexes in patients with psoriasis.
Hall RP; Peck GL; Lawley TJ
J Invest Dermatol; 1983 Jun; 80(6):465-8. PubMed ID: 6602187
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
11. A Clq solid phase microenzymatic assay for the detection of soluble immune complexes.
Cordiali Fei P; Natali PG
Ric Clin Lab; 1981; 11(3):207-14. PubMed ID: 6974886
[TBL] [Abstract][Full Text] [Related]
12. Dermatitis herpetiformis: immune complex detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Tappeiner G; Kahl JC; Wolff K
Br J Dermatol; 1981 Aug; 105(2):159-65. PubMed ID: 7025879
[TBL] [Abstract][Full Text] [Related]
13. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
14. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
Wager O; Lindstrøm P
Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
16. C1q binding activity in the sera of patients with chronic lung diseases.
Cooper KM; Moore M; Hilton AM
Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
[TBL] [Abstract][Full Text] [Related]
17. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
[TBL] [Abstract][Full Text] [Related]
19. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
20. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Struve MF; Bushkell LL
Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
